Assessment of hepatic insulin action in obese type 2 diabetic patients

Diabetes

Volumn 50, Issue 6, 2001, Pages 1363-1370

  Staehr, Peter ^a   Hother Nielsen, Ole ^a   Levin, Klaus ^a   Holst, Jens Juul ^b   Beck Nielsen, Henning ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

AI, arterial insulin; FFA, free fatty acid; HGP, hepatic glucose production; HSI, hepatic sinusoidal insulin; OGTT, oral glucose tolerance test; Ra, rate of appearance; Rd, rate of disposal

Indexed keywords

FATTY ACID; GLUCAGON; GLUCOSE; INSULIN; NEUTRAL INSULIN; TRACER; TRITIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC OBESITY; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN RESISTANCE; LIVER SINUSOID; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0034981290     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.6.1363     Document Type: Article

References (37)

1. Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus?
2. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: A balanced overview
3. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes
4. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: The role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia: A critical comment
5. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: Evidence for multiple sites of insulin resistance
6. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus
7. Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus
8. Insulin action in non-insulin-dependent diabetes mellitus: The relationship between hepatic and extrahepatic insulin resistance and obesity
9. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus
10. Hepatic and extrahepatic responses to insulin in NIDDM and non-diabetic humans: Assessment in absence of artifact introduced by tritiated nonglucose contaminants
11. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM: Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation
12. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin-dependent diabetes mellitus
13. Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus
14. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: Comparison of unlabelled and labelled exogenous glucose infusates
15. Assessment of glucose turnover rates in euglycaemic clamp studies using [3-3H]-glucose infusion and labelled or unlabelled glucose infusates
16. Effects of insulin on glucose turnover in vivo: Isotope dilution versus constant specific activity technique
17. Labelled glucose infusate technique in clamp studies: Is precise matching of glucose specific activity important?
18. Evidence that glicentin contains the entire sequence of glucagon
19. The direct and indirect effects of insulin on hepatic glucose production in vivo
20. Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients
21. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues
22. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
23. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM
24. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: Normalization of glucose kinetics by short term fasting
25. Effect of lipid infusion on postabsorptive glucose metabolism in non-insulin-dependent diabetic patients
26. Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM
27. Pharmacologic therapy for type 2 diabetes mellitus
28. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects
29. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia
30. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs
31. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects
32. Contribution of gluconeogenesis to glucose production in mild type 2 diabetes
33. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: A quantitative study
34. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
35. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans
36. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes
37. Euglycemia acutely restores the direct hepatic effect of insulin on glucose production in depancreatized dogs